Amundi
MEDP icon

Amundi’s Medpace MEDP Stock Holding History

Amundi’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.4M Buy
61,139
+57,288
+1,488% +$29.3M 0.01% 701
2025
Q4 		$2.16M Sell
3,851
-19,406
-83% -$11M ﹤0.01% 1150
2025
Q3 		$12.3M Buy
23,257
+9,145
+65% +$3.99M ﹤0.01% 823
2025
Q2 		$4.6M Buy
14,112
+13,436
+1,988% +$4.03M ﹤0.01% 941
2025
Q1 		$206K Sell
676
-3,627
-84% -$1.22M ﹤0.01% 1672
2024
Q4 		$1.53M Buy
4,303
+65
+2% +$22K ﹤0.01% 1283
2024
Q3 		$1.43M Sell
4,238
-12,664
-75% -$4.81M ﹤0.01% 1215
2024
Q2 		$6.81M Sell
16,902
-371
-2% -$147K ﹤0.01% 910
2024
Q1 		$6.47M Buy
17,273
+2,864
+20% +$1.01M ﹤0.01% 917
2023
Q4 		$4.33M Sell
14,409
-8,465
-37% -$2.28M ﹤0.01% 1011
2023
Q3 		$5.47M Buy
22,874
+21,366
+1,417% +$5.46M ﹤0.01% 954
2023
Q2 		$360K Hold
1,508
– – ﹤0.01% 1460
2023
Q1 		$285K Sell
1,508
-105
-7% -$21.7K ﹤0.01% 1481
2022
Q4 		$366K Sell
1,613
-55
-3% -$11K ﹤0.01% 1446
2022
Q3 		$279K Hold
1,668
– – ﹤0.01% 1415
2022
Q2 		$247K Sell
1,668
-162
-9% -$23.5K ﹤0.01% 1341
2022
Q1 		$304K Sell
1,830
-357
-16% -$58.9K ﹤0.01% 1343
2021
Q4 		$394K Buy
2,187
+1,176
+116% +$246K ﹤0.01% 1418
2021
Q3 		$191K Sell
1,011
-35,708
-97% -$6.51M ﹤0.01% 1444
2021
Q2 		$6.49M Buy
+36,719
New +$6.34M ﹤0.01% 946

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Amundi's MEDP Position: Q1 2026 in Review

Amundi increased its Medpace (MEDP) stake by 1,488% in Q1 2026, buying an estimated $29.3M and bringing the position to 61,139 shares worth $29.4M. The position accounts for 0.01% of the portfolio, ranked #701.

Amundi first reported a position in MEDP in Q2 2021 and has held it in 20 quarters since. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Amundi held 61,139 shares of Medpace worth $29.4M as of Q1 2026.
  • Amundi bought 57,288 Medpace shares in Q1 2026, an estimated $29.3M.
  • Medpace made up 0.01% of Amundi's portfolio in Q1 2026, its #701 holding.
  • Amundi first reported a position in Medpace in Q2 2021 and has held it in 20 quarters since.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.